Citigroup Cuts Hologic (NASDAQ:HOLX) Price Target to $70.00
Hologic (NASDAQ:HOLX – Get Free Report) had its price target lowered by analysts at Citigroup from $80.00 to $70.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the medical equipment provider’s stock. Citigroup’s price objective suggests a potential upside of 12.76% from the company’s previous close. Several other […]
Hologic (NASDAQ:HOLX – Get Free Report) had its price target lowered by analysts at Citigroup from $80.00 to $70.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the medical equipment provider’s stock. Citigroup’s price objective suggests a potential upside of 12.76% from the company’s previous close. Several other […]
